Targeted Therapy for Severe Asthma: Identifying the Right Patients (original) (raw)
Related papers
World Allergy Organization Journal, 2021
Can biomarkers help us hit targets in difficult-to-treat asthma?
Respirology (Carlton, Vic.), 2017
Respiratory medicine, 2018
Responses to biological therapies in eosinophilic severe asthma
Journal of Investigational Allergology and Clinical Immunology, 2019
Journal of Investigational Allergology and Clinical Immunology, 2019
Respiratory Medicine, 2019
Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice
Journal of Personalized Medicine
Severe Asthma and Biological Therapy: When, Which, and for Whom
Pulmonary therapy, 2019
Towards clinically applicable biomarkers for asthma – An EAACI position paper
Allergy
Biomarkers and severe asthma: a critical appraisal
Clinical and Molecular Allergy, 2015
Toward clinically applicable biomarkers for asthma: An EAACI position paper
Allergy, 2019
Hallmarks Cytokines on Eosinophils and Asthma Single and Synergistic Effects of Type 2
Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma
The Journal of Allergy and Clinical Immunology: In Practice, 2020
Eosinophils Target Therapy for Severe Asthma: Critical Points
BioMed Research International
Biologic and New Therapies in Asthma
Immunology and allergy clinics of North America, 2017
Value of peripheral blood eosinophil markers to predict severity of asthma
BMC pulmonary medicine, 2016
Biomarkers of therapy responsiveness in asthma: pitfalls and promises
Clinical & Experimental Allergy, 2011
Variability of blood eosinophil count as an asthma biomarker
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
Biomedicines, 2022
Eosinophilic bioactivities in severe asthma
The World Allergy Organization journal, 2016
Variability of blood eosinophils in patients in a clinic for severe asthma
Clinical & Experimental Allergy, 2018
Antibody therapy for the management of severe asthma with eosinophilic inflammation
International Immunology, 2017
Clinical & Experimental Allergy, 2022
Phenotyping severe asthma: a rationale for biologic therapy
Expert Review of Precision Medicine and Drug Development, 2020
Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
Journal of Asthma and Allergy
Asthma and Lung Biology [Working Title]
Clinical control of asthma associates with measures of airway inflammation
Thorax, 2013
The Lancet Respiratory Medicine, 2014
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
New England Journal of Medicine, 2013
2016